The global Diagnostic Radioisotopes market was valued at US$ 4722 million in 2023 and is anticipated to reach US$ 7534.8 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.

Diagnostic Radioisotopes Market

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radioisotopes.

Report Scope

The Diagnostic Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Radioisotopes Market Report

Report Metric	Details
Report Name	Diagnostic Radioisotopes Market
Accounted market size in 2023	US$ 4722 million
Forecasted market size in 2030	US$ 7534.8 million
CAGR	6.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tc-99m F-18 Other
Segment by Application	Oncology Cardiology Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Radioisotopes Market growing?

Ans: The Diagnostic Radioisotopes Market witnessing a CAGR of 6.9% during the forecast period 2024-2030.

What is the Diagnostic Radioisotopes Market size in 2030?

Ans: The Diagnostic Radioisotopes Market size in 2030 will be US$ 7534.8 million.

Who are the main players in the Diagnostic Radioisotopes Market report?

Ans: The main players in the Diagnostic Radioisotopes Market are Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly

What are the Application segmentation covered in the Diagnostic Radioisotopes Market report?

Ans: The Applications covered in the Diagnostic Radioisotopes Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Diagnostic Radioisotopes Market report?

Ans: The Types covered in the Diagnostic Radioisotopes Market report are Tc-99m, F-18, Other

1 Diagnostic Radioisotopes Market Overview

1.1 Product Overview and Scope of Diagnostic Radioisotopes

1.2 Diagnostic Radioisotopes Segment by Type

1.2.1 Global Diagnostic Radioisotopes Market Value Comparison by Type (2024-2030)

1.2.2 Tc-99m

1.2.3 F-18

1.2.4 Other

1.3 Diagnostic Radioisotopes Segment by Application

1.3.1 Global Diagnostic Radioisotopes Market Value by Application: (2024-2030)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Diagnostic Radioisotopes Market Size Estimates and Forecasts

1.4.1 Global Diagnostic Radioisotopes Revenue 2019-2030

1.4.2 Global Diagnostic Radioisotopes Sales 2019-2030

1.4.3 Global Diagnostic Radioisotopes Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Diagnostic Radioisotopes Market Competition by Manufacturers

2.1 Global Diagnostic Radioisotopes Sales Market Share by Manufacturers (2019-2024)

2.2 Global Diagnostic Radioisotopes Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Diagnostic Radioisotopes Average Price by Manufacturers (2019-2024)

2.4 Global Diagnostic Radioisotopes Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Diagnostic Radioisotopes, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Diagnostic Radioisotopes, Product Type & Application

2.7 Diagnostic Radioisotopes Market Competitive Situation and Trends

2.7.1 Diagnostic Radioisotopes Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Radioisotopes Players Market Share by Revenue

2.7.3 Global Diagnostic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Radioisotopes Retrospective Market Scenario by Region

3.1 Global Diagnostic Radioisotopes Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Diagnostic Radioisotopes Global Diagnostic Radioisotopes Sales by Region: 2019-2030

3.2.1 Global Diagnostic Radioisotopes Sales by Region: 2019-2024

3.2.2 Global Diagnostic Radioisotopes Sales by Region: 2025-2030

3.3 Global Diagnostic Radioisotopes Global Diagnostic Radioisotopes Revenue by Region: 2019-2030

3.3.1 Global Diagnostic Radioisotopes Revenue by Region: 2019-2024

3.3.2 Global Diagnostic Radioisotopes Revenue by Region: 2025-2030

3.4 North America Diagnostic Radioisotopes Market Facts & Figures by Country

3.4.1 North America Diagnostic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Diagnostic Radioisotopes Sales by Country (2019-2030)

3.4.3 North America Diagnostic Radioisotopes Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Diagnostic Radioisotopes Market Facts & Figures by Country

3.5.1 Europe Diagnostic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Diagnostic Radioisotopes Sales by Country (2019-2030)

3.5.3 Europe Diagnostic Radioisotopes Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Diagnostic Radioisotopes Market Facts & Figures by Country

3.6.1 Asia Pacific Diagnostic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Diagnostic Radioisotopes Sales by Country (2019-2030)

3.6.3 Asia Pacific Diagnostic Radioisotopes Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Diagnostic Radioisotopes Market Facts & Figures by Country

3.7.1 Latin America Diagnostic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Diagnostic Radioisotopes Sales by Country (2019-2030)

3.7.3 Latin America Diagnostic Radioisotopes Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Diagnostic Radioisotopes Market Facts & Figures by Country

3.8.1 Middle East and Africa Diagnostic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Diagnostic Radioisotopes Sales by Country (2019-2030)

3.8.3 Middle East and Africa Diagnostic Radioisotopes Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Diagnostic Radioisotopes Sales by Type (2019-2030)

4.1.1 Global Diagnostic Radioisotopes Sales by Type (2019-2024)

4.1.2 Global Diagnostic Radioisotopes Sales by Type (2025-2030)

4.1.3 Global Diagnostic Radioisotopes Sales Market Share by Type (2019-2030)

4.2 Global Diagnostic Radioisotopes Revenue by Type (2019-2030)

4.2.1 Global Diagnostic Radioisotopes Revenue by Type (2019-2024)

4.2.2 Global Diagnostic Radioisotopes Revenue by Type (2025-2030)

4.2.3 Global Diagnostic Radioisotopes Revenue Market Share by Type (2019-2030)

4.3 Global Diagnostic Radioisotopes Price by Type (2019-2030)

5 Segment by Application

5.1 Global Diagnostic Radioisotopes Sales by Application (2019-2030)

5.1.1 Global Diagnostic Radioisotopes Sales by Application (2019-2024)

5.1.2 Global Diagnostic Radioisotopes Sales by Application (2025-2030)

5.1.3 Global Diagnostic Radioisotopes Sales Market Share by Application (2019-2030)

5.2 Global Diagnostic Radioisotopes Revenue by Application (2019-2030)

5.2.1 Global Diagnostic Radioisotopes Revenue by Application (2019-2024)

5.2.2 Global Diagnostic Radioisotopes Revenue by Application (2025-2030)

5.2.3 Global Diagnostic Radioisotopes Revenue Market Share by Application (2019-2030)

5.3 Global Diagnostic Radioisotopes Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Cardinal Health

6.1.1 Cardinal Health Corporation Information

6.1.2 Cardinal Health Description and Business Overview

6.1.3 Cardinal Health Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Cardinal Health Diagnostic Radioisotopes Product Portfolio

6.1.5 Cardinal Health Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Corporation Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GE Healthcare Diagnostic Radioisotopes Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Curium Pharma

6.3.1 Curium Pharma Corporation Information

6.3.2 Curium Pharma Description and Business Overview

6.3.3 Curium Pharma Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Curium Pharma Diagnostic Radioisotopes Product Portfolio

6.3.5 Curium Pharma Recent Developments/Updates

6.4 Jubilant Pharma

6.4.1 Jubilant Pharma Corporation Information

6.4.2 Jubilant Pharma Description and Business Overview

6.4.3 Jubilant Pharma Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jubilant Pharma Diagnostic Radioisotopes Product Portfolio

6.4.5 Jubilant Pharma Recent Developments/Updates

6.5 Bracco Imaging

6.5.1 Bracco Imaging Corporation Information

6.5.2 Bracco Imaging Description and Business Overview

6.5.3 Bracco Imaging Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bracco Imaging Diagnostic Radioisotopes Product Portfolio

6.5.5 Bracco Imaging Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novartis Diagnostic Radioisotopes Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 SIEMENS

6.6.1 SIEMENS Corporation Information

6.6.2 SIEMENS Description and Business Overview

6.6.3 SIEMENS Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SIEMENS Diagnostic Radioisotopes Product Portfolio

6.7.5 SIEMENS Recent Developments/Updates

6.8 China Isotope & Radiation

6.8.1 China Isotope & Radiation Corporation Information

6.8.2 China Isotope & Radiation Description and Business Overview

6.8.3 China Isotope & Radiation Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.8.4 China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio

6.8.5 China Isotope & Radiation Recent Developments/Updates

6.9 Dongcheng

6.9.1 Dongcheng Corporation Information

6.9.2 Dongcheng Description and Business Overview

6.9.3 Dongcheng Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Dongcheng Diagnostic Radioisotopes Product Portfolio

6.9.5 Dongcheng Recent Developments/Updates

6.10 Lantheus

6.10.1 Lantheus Corporation Information

6.10.2 Lantheus Description and Business Overview

6.10.3 Lantheus Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Lantheus Diagnostic Radioisotopes Product Portfolio

6.10.5 Lantheus Recent Developments/Updates

6.11 Eli Lilly

6.11.1 Eli Lilly Corporation Information

6.11.2 Eli Lilly Diagnostic Radioisotopes Description and Business Overview

6.11.3 Eli Lilly Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Eli Lilly Diagnostic Radioisotopes Product Portfolio

6.11.5 Eli Lilly Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Diagnostic Radioisotopes Industry Chain Analysis

7.2 Diagnostic Radioisotopes Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Diagnostic Radioisotopes Production Mode & Process

7.4 Diagnostic Radioisotopes Sales and Marketing

7.4.1 Diagnostic Radioisotopes Sales Channels

7.4.2 Diagnostic Radioisotopes Distributors

7.5 Diagnostic Radioisotopes Customers

8 Diagnostic Radioisotopes Market Dynamics

8.1 Diagnostic Radioisotopes Industry Trends

8.2 Diagnostic Radioisotopes Market Drivers

8.3 Diagnostic Radioisotopes Market Challenges

8.4 Diagnostic Radioisotopes Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bracco Imaging

Lantheus

GE Healthcare

China Isotope & Radiation

List of Tables

Table 1. Global Diagnostic Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Diagnostic Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Diagnostic Radioisotopes Market Competitive Situation by Manufacturers in 2023

Table 4. Global Diagnostic Radioisotopes Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Diagnostic Radioisotopes Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Diagnostic Radioisotopes Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Diagnostic Radioisotopes Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Diagnostic Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Diagnostic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Diagnostic Radioisotopes, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Diagnostic Radioisotopes, Product Type & Application

Table 12. Global Key Manufacturers of Diagnostic Radioisotopes, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Diagnostic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radioisotopes as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Diagnostic Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Diagnostic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 18. Global Diagnostic Radioisotopes Sales Market Share by Region (2019-2024)

Table 19. Global Diagnostic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 20. Global Diagnostic Radioisotopes Sales Market Share by Region (2025-2030)

Table 21. Global Diagnostic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Diagnostic Radioisotopes Revenue Market Share by Region (2019-2024)

Table 23. Global Diagnostic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Diagnostic Radioisotopes Revenue Market Share by Region (2025-2030)

Table 25. North America Diagnostic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Diagnostic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 27. North America Diagnostic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 28. North America Diagnostic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Diagnostic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Diagnostic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Diagnostic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 32. Europe Diagnostic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 33. Europe Diagnostic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Diagnostic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Diagnostic Radioisotopes Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Diagnostic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Diagnostic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Diagnostic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Diagnostic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Diagnostic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Diagnostic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Diagnostic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Diagnostic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Diagnostic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Diagnostic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Diagnostic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Diagnostic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Diagnostic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Diagnostic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Diagnostic Radioisotopes Sales (K Units) by Type (2019-2024)

Table 51. Global Diagnostic Radioisotopes Sales (K Units) by Type (2025-2030)

Table 52. Global Diagnostic Radioisotopes Sales Market Share by Type (2019-2024)

Table 53. Global Diagnostic Radioisotopes Sales Market Share by Type (2025-2030)

Table 54. Global Diagnostic Radioisotopes Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Diagnostic Radioisotopes Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Diagnostic Radioisotopes Revenue Market Share by Type (2019-2024)

Table 57. Global Diagnostic Radioisotopes Revenue Market Share by Type (2025-2030)

Table 58. Global Diagnostic Radioisotopes Price (USD/Unit) by Type (2019-2024)

Table 59. Global Diagnostic Radioisotopes Price (USD/Unit) by Type (2025-2030)

Table 60. Global Diagnostic Radioisotopes Sales (K Units) by Application (2019-2024)

Table 61. Global Diagnostic Radioisotopes Sales (K Units) by Application (2025-2030)

Table 62. Global Diagnostic Radioisotopes Sales Market Share by Application (2019-2024)

Table 63. Global Diagnostic Radioisotopes Sales Market Share by Application (2025-2030)

Table 64. Global Diagnostic Radioisotopes Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Diagnostic Radioisotopes Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Diagnostic Radioisotopes Revenue Market Share by Application (2019-2024)

Table 67. Global Diagnostic Radioisotopes Revenue Market Share by Application (2025-2030)

Table 68. Global Diagnostic Radioisotopes Price (USD/Unit) by Application (2019-2024)

Table 69. Global Diagnostic Radioisotopes Price (USD/Unit) by Application (2025-2030)

Table 70. Cardinal Health Corporation Information

Table 71. Cardinal Health Description and Business Overview

Table 72. Cardinal Health Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Cardinal Health Diagnostic Radioisotopes Product

Table 74. Cardinal Health Recent Developments/Updates

Table 75. GE Healthcare Corporation Information

Table 76. GE Healthcare Description and Business Overview

Table 77. GE Healthcare Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. GE Healthcare Diagnostic Radioisotopes Product

Table 79. GE Healthcare Recent Developments/Updates

Table 80. Curium Pharma Corporation Information

Table 81. Curium Pharma Description and Business Overview

Table 82. Curium Pharma Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Curium Pharma Diagnostic Radioisotopes Product

Table 84. Curium Pharma Recent Developments/Updates

Table 85. Jubilant Pharma Corporation Information

Table 86. Jubilant Pharma Description and Business Overview

Table 87. Jubilant Pharma Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Jubilant Pharma Diagnostic Radioisotopes Product

Table 89. Jubilant Pharma Recent Developments/Updates

Table 90. Bracco Imaging Corporation Information

Table 91. Bracco Imaging Description and Business Overview

Table 92. Bracco Imaging Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Bracco Imaging Diagnostic Radioisotopes Product

Table 94. Bracco Imaging Recent Developments/Updates

Table 95. Novartis Corporation Information

Table 96. Novartis Description and Business Overview

Table 97. Novartis Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Novartis Diagnostic Radioisotopes Product

Table 99. Novartis Recent Developments/Updates

Table 100. SIEMENS Corporation Information

Table 101. SIEMENS Description and Business Overview

Table 102. SIEMENS Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. SIEMENS Diagnostic Radioisotopes Product

Table 104. SIEMENS Recent Developments/Updates

Table 105. China Isotope & Radiation Corporation Information

Table 106. China Isotope & Radiation Description and Business Overview

Table 107. China Isotope & Radiation Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. China Isotope & Radiation Diagnostic Radioisotopes Product

Table 109. China Isotope & Radiation Recent Developments/Updates

Table 110. Dongcheng Corporation Information

Table 111. Dongcheng Description and Business Overview

Table 112. Dongcheng Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Dongcheng Diagnostic Radioisotopes Product

Table 114. Dongcheng Recent Developments/Updates

Table 115. Lantheus Corporation Information

Table 116. Lantheus Description and Business Overview

Table 117. Lantheus Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Lantheus Diagnostic Radioisotopes Product

Table 119. Lantheus Recent Developments/Updates

Table 120. Eli Lilly Corporation Information

Table 121. Eli Lilly Description and Business Overview

Table 122. Eli Lilly Diagnostic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Eli Lilly Diagnostic Radioisotopes Product

Table 124. Eli Lilly Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Diagnostic Radioisotopes Distributors List

Table 128. Diagnostic Radioisotopes Customers List

Table 129. Diagnostic Radioisotopes Market Trends

Table 130. Diagnostic Radioisotopes Market Drivers

Table 131. Diagnostic Radioisotopes Market Challenges

Table 132. Diagnostic Radioisotopes Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Diagnostic Radioisotopes

Figure 2. Global Diagnostic Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Diagnostic Radioisotopes Market Share by Type in 2023 & 2030

Figure 4. Tc-99m Product Picture

Figure 5. F-18 Product Picture

Figure 6. Other Product Picture

Figure 7. Global Diagnostic Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Diagnostic Radioisotopes Market Share by Application in 2023 & 2030

Figure 9. Oncology

Figure 10. Cardiology

Figure 11. Other

Figure 12. Global Diagnostic Radioisotopes Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diagnostic Radioisotopes Market Size (2019-2030) & (US$ Million)

Figure 14. Global Diagnostic Radioisotopes Sales (2019-2030) & (K Units)

Figure 15. Global Diagnostic Radioisotopes Average Price (USD/Unit) & (2019-2030)

Figure 16. Diagnostic Radioisotopes Report Years Considered

Figure 17. Diagnostic Radioisotopes Sales Share by Manufacturers in 2023

Figure 18. Global Diagnostic Radioisotopes Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Diagnostic Radioisotopes Players: Market Share by Revenue in 2023

Figure 20. Diagnostic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Diagnostic Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Diagnostic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 23. North America Diagnostic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Diagnostic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 27. Europe Diagnostic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 28. Germany Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Diagnostic Radioisotopes Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Diagnostic Radioisotopes Revenue Market Share by Region (2019-2030)

Figure 35. China Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Diagnostic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 46. Latin America Diagnostic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Diagnostic Radioisotopes Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Diagnostic Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Diagnostic Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Diagnostic Radioisotopes by Type (2019-2030)

Figure 56. Global Revenue Market Share of Diagnostic Radioisotopes by Type (2019-2030)

Figure 57. Global Diagnostic Radioisotopes Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Diagnostic Radioisotopes by Application (2019-2030)

Figure 59. Global Revenue Market Share of Diagnostic Radioisotopes by Application (2019-2030)

Figure 60. Global Diagnostic Radioisotopes Price (USD/Unit) by Application (2019-2030)

Figure 61. Diagnostic Radioisotopes Value Chain

Figure 62. Diagnostic Radioisotopes Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions